{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:33:27Z","timestamp":1780634007232,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007405","name":"Hjerteforeningen","doi-asserted-by":"publisher","award":["16-R107-A6776-22972"],"award-info":[{"award-number":["16-R107-A6776-22972"]}],"id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007405","name":"Hjerteforeningen","doi-asserted-by":"publisher","award":["17-R115-A7443-22062"],"award-info":[{"award-number":["17-R115-A7443-22062"]}],"id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.hrthm.2019.05.018","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T02:44:19Z","timestamp":1558406659000},"page":"1348-1356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Rate and rhythm therapy in patients with atrial fibrillation and the risk of pacing and bradyarrhythmia"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7287-4191","authenticated-orcid":false,"given":"Frederik","family":"Dalgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannik L.","family":"Pallisgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommi Bo","family":"Lindhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Torp-Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar H.","family":"Gislason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"Ruwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2019.05.018_bib1","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.018_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0735-1097(02)02709-2","article-title":"Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction","volume":"41","author":"Essebag","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.018_bib3","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1540-8159.2004.00597.x","article-title":"Drug induced bradycardia: to pace or not to pace?","volume":"27","author":"Ovsyshcher","year":"2004","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.018_bib4","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0002-9149(03)00395-3","article-title":"Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter","volume":"91","author":"Hauser","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.018_bib5","first-page":"29","article-title":"Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers","volume":"7","author":"Kawabata","year":"2015","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.hrthm.2019.05.018_bib6","first-page":"640","article-title":"[Symptomatic bradycardia with amiodarone in patients with pre-existing conduction disorders]","volume":"107","author":"Hofmann","year":"1995","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.hrthm.2019.05.018_bib7","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/europace\/eus154","article-title":"The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide study","volume":"14","author":"Ruwald","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2019.05.018_bib8","series-title":"Advances in the Treatment of Atrial Tachyarrhythmias: Pacing, Cardioversion, and Defibrillation","first-page":"305","article-title":"Treatment of tachyarrhythmias with pacing and antiarrhythmic drugs","author":"Israel","year":"2002"},{"key":"10.1016\/j.hrthm.2019.05.018_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4070\/kcj.2009.39.9.367","article-title":"Prognosis and natural history of drug-related bradycardia","volume":"39","author":"Lee","year":"2009","journal-title":"Korean Circ J"},{"key":"10.1016\/j.hrthm.2019.05.018_bib10","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/europace\/eut206","volume":"15","author":"Brignole","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2019.05.018_bib11","first-page":"CD005049","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation","author":"Lafuente-Lafuente","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hrthm.2019.05.018_bib12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.hrthm.2019.05.018_bib13","doi-asserted-by":"crossref","first-page":"d124","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.hrthm.2019.05.018_bib14","doi-asserted-by":"crossref","first-page":"e012817","DOI":"10.1136\/bmjopen-2016-012817","article-title":"Positive predictive value of cardiac examination, procedure and surgery codes in the Danish National Patient Registry: a population-based validation study","volume":"6","author":"Adelborg","year":"2016","journal-title":"BMJ Open"},{"issue":"15","key":"10.1016\/j.hrthm.2019.05.018_bib15","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1002\/sim.2764","article-title":"Age\u2013period\u2013cohort models for the Lexis diagram","volume":"26","author":"Carstensen","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.hrthm.2019.05.018_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-127-4-199708150-00004","article-title":"Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital","volume":"127","author":"Maisel","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2019.05.018_bib17","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2019.05.018_bib18","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.hrthm.2010.04.026","article-title":"Antiarrhythmic use from 1991 to 2007: Insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II)","volume":"7","author":"Andrade","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.018_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2710.1995.tb00646.x","article-title":"Digoxin-quinidine and digoxin-amiodarone interactions: frequency of occurrence and monitoring in Australian repatriation hospitals","volume":"20","author":"Freitag","year":"1995","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.hrthm.2019.05.018_bib20","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1001\/archinte.167.15.1648","article-title":"Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation","volume":"167","author":"Essebag","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrthm.2019.05.018_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2165\/00003088-198409020-00002","article-title":"Clinical pharmacokinetics of amiodarone","volume":"9","author":"Latini","year":"1984","journal-title":"Clin Pharmacokinet"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154752711930459X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154752711930459X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:48:41Z","timestamp":1761547721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154752711930459X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S154752711930459X"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2019.05.018","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rate and rhythm therapy in patients with atrial fibrillation and the risk of pacing and bradyarrhythmia","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2019.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}